eLife (Jul 2020)
Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma
- Allison N Lau,
- Zhaoqi Li,
- Laura V Danai,
- Anna M Westermark,
- Alicia M Darnell,
- Raphael Ferreira,
- Vasilena Gocheva,
- Sharanya Sivanand,
- Evan C Lien,
- Kiera M Sapp,
- Jared R Mayers,
- Giulia Biffi,
- Christopher R Chin,
- Shawn M Davidson,
- David A Tuveson,
- Tyler Jacks,
- Nicholas J Matheson,
- Omer Yilmaz,
- Matthew G Vander Heiden
Affiliations
- Allison N Lau
- ORCiD
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States
- Zhaoqi Li
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States
- Laura V Danai
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States; Department of Biochemistry and Molecular Biology, University of Massachusetts, Amherst, Amherst, United States
- Anna M Westermark
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States
- Alicia M Darnell
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States
- Raphael Ferreira
- ORCiD
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States; Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
- Vasilena Gocheva
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States
- Sharanya Sivanand
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States
- Evan C Lien
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States
- Kiera M Sapp
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States
- Jared R Mayers
- ORCiD
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States
- Giulia Biffi
- Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, United States; Lustgarten Foundation Pancreatic Cancer Research Laboratory, Cold Spring Harbor, New York, United States; Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Cambridge, United Kingdom
- Christopher R Chin
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States
- Shawn M Davidson
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States; Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, United States; Department of Molecular Biology, Princeton University, Princeton, United States
- David A Tuveson
- Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, United States; Lustgarten Foundation Pancreatic Cancer Research Laboratory, Cold Spring Harbor, New York, United States
- Tyler Jacks
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States
- Nicholas J Matheson
- ORCiD
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States; Department of Medicine, University of Cambridge, Cambridge, United Kingdom; Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom
- Omer Yilmaz
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States; Department of Pathology, Massachusetts General Hospital, Boston, United States
- Matthew G Vander Heiden
- ORCiD
- Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, United States; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States
- DOI
- https://doi.org/10.7554/eLife.56782
- Journal volume & issue
-
Vol. 9
Abstract
Tumors are composed of many different cell types including cancer cells, fibroblasts, and immune cells. Dissecting functional metabolic differences between cell types within a mixed population can be challenging due to the rapid turnover of metabolites relative to the time needed to isolate cells. To overcome this challenge, we traced isotope-labeled nutrients into macromolecules that turn over more slowly than metabolites. This approach was used to assess differences between cancer cell and fibroblast metabolism in murine pancreatic cancer organoid-fibroblast co-cultures and tumors. Pancreatic cancer cells exhibited increased pyruvate carboxylation relative to fibroblasts, and this flux depended on both pyruvate carboxylase and malic enzyme 1 activity. Consequently, expression of both enzymes in cancer cells was necessary for organoid and tumor growth, demonstrating that dissecting the metabolism of specific cell populations within heterogeneous systems can identify dependencies that may not be evident from studying isolated cells in culture or bulk tissue.
Keywords